Abstract
The present invention relates to a pharmaceutical composition containing bosentan. According to the present invention, a pharmaceutical composition containing bosentan has an excellent lung-targeting drug delivery property while enabling the drug toxicity of bosentane to be minimized because of the organic combination of bosentane and preparation ingredients, and has a longer drug action duration while enabling a reduction in the frequency of drug administration, thereby being effectively usable as an inhalant formulation.


Keywords
Similar
Note
Team Comments
More Comment

Original Text
Translate